Medgend Icon

Ledgend of Medicine







discontinued


Cotempla Xr-odt

Is it hard for your child to sit still? Does your child act without thinking first? Does your child start but not finish things? If so, your child may have attention deficit hyperactivity disorder (ADHD). Nearly everyone shows some of these behaviors at times, but ADHD lasts more than 6 months and causes problems in school, at home and in social situations.

ADHD is more common in boys than girls. It affects 3 to 5% of all American children.

The main features of ADHD are

  • Inattention
  • Hyperactivity
  • Impulsivity

No one knows exactly what causes ADHD. It sometimes runs in families, so genetics may be a factor. There may also be environmental factors.

A complete evaluation by a trained professional is the only way to know for sure if your child has ADHD. Treatment may include medicine to control symptoms, therapy, or both. Structure at home and at school is important. Parent training may also help.

NIH: National Institute of Mental Health

Cotempla Xr-odt FDA Approved Drugs

COTEMPLA XR-ODT [MethylphenidateC14H19NO2]
RX
-
17.3mg (oral tablet, orally disintegrating, extended release)
25.9mg (oral tablet, orally disintegrating, extended release)
8.6mg (oral tablet, orally disintegrating, extended release)
Neos Theraps IncJun 19, 2017
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

DAYTRANA [MethylphenidateC14H19NO2]
RX
-
10mg/9hr (1.1mg/hr) (transdermal film, extended release)
15mg/9hr (1.6mg/hr) (transdermal film, extended release)
20mg/9hr (2.2mg/hr) (transdermal film, extended release)
30mg/9hr (3.3mg/hr) (transdermal film, extended release)
Noven Pharms IncApr 6, 2006
  • For the treatment of attention deficit hyperactivity disorder (adhd).
  • Method for transdermally delivering a drug to a user in need thereof.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.